Kristina Meyer
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Kristina Meyer
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Evotec (UK) Ltd.
Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The company is based in Abingdon, UK and was founded in 1991.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Kristina Meyer tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
SEAGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Director/Board Member | |
Spinifex Pty Ltd. | Director/Board Member | ||
Atlantic Pharmaceuticals (Holdings) Ltd. | Director/Board Member | ||
Liverpool Health Partners Ltd. | Chairman | ||
Genomics England Ltd.
Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | Pharmaceuticals: Major | Chief Executive Officer | |
Ochre Bio Ltd.
Ochre Bio Ltd. Pharmaceuticals: MajorHealth Technology Ochre Bio Ltd. is a biotechnology company based in Headington, UK. Ochre Bio is focused on developing RNA medicines for chronic liver diseases. The British company uses deep phenotyping, precision RNA medicine, and testing in live human donor livers to develop therapies for important liver health challenges. The company's goal is to develop therapies that increase donor liver supply and reduce cirrhosis complications. The company was founded by Quin Wills and the CEO is Jack O'Meara. | Pharmaceuticals: Major | Chairman | |
PROTALIX BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
Tessellate Bio BV
Tessellate Bio BV BiotechnologyHealth Technology Tessellate Bio BV is a Dutch preclinical stage biotechnology company that focuses on discovering and developing precision oncology medicines. The company is based in Naarden, the Netherlands. The company's mission is to turn cancer patients into cancer survivors by targeting unexplored or difficult to drug pathways beyond HRD. The company is also developing companion diagnostics, including a potentially diagnostic to detect ALT positive cancers. Led by an experienced team of drug hunters, Tessellate Bio is building a pipeline of first-in-class medicines based on cutting-edge research. The company was founded by Hilda A. Pickett and the CEO is Andree Blaukat. | Biotechnology | Director/Board Member | |
Levicept Ltd.
Levicept Ltd. Pharmaceuticals: GenericHealth Technology Levicept Ltd. develops a biological therapy for the treatment of osteoarthritis and chronic pain. Its treatments include p75NTR-Fc and LEVI-04. The company was founded by Simon Lempriere Westbrook on August 23, 2012 and is headquartered in Sandwich, the United Kingdom. | Pharmaceuticals: Generic | Chief Executive Officer | |
The University of Nottingham | College/University | Doctorate Degree | |
Creabilis SA | Chief Executive Officer | ||
CRISPR THERAPEUTICS AG | Biotechnology | Chief Tech/Sci/R&D Officer | |
CytomX Therapeutics Holdings LLC
CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology CytomX Therapeutics Holdings LLC engaged in the development of new generation targeted antibody therapeutics. The company was founded by Frederick W. Gluck on January 31, 2008 and is headquartered in Santa Barbara, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Celltech R&D Ltd.
Celltech R&D Ltd. Miscellaneous Commercial ServicesCommercial Services Part of UCB SA, Celltech R & D Ltd. is a British company that engages in drug discovery and development. The company is based in Slough, UK. Celltech R&D Ltd. was founded in 1980. | Miscellaneous Commercial Services | Director/Board Member | |
The University of Sheffield | College/University | Undergraduate Degree | |
Isarna Therapeutics GmbH
Isarna Therapeutics GmbH BiotechnologyHealth Technology Isarna Therapeutics GmbH engages in developing selective TGF-ß inhibitors. It works on a pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcome. The company focuses on biopharmaceutical research, pipeline development, and partnering and licensing programs. Isarna Therapeutics was founded by Karl-Hermann Schlingensiepen and Reimar Schlingensiepen in 1998 and is headquartered in Munich, Germany. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Colorado State University | College/University | Masters Business Admin | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Corporate Officer/Principal | |
Ruprecht-Karls-Universität Heidelberg | College/University | Corporate Officer/Principal | |
Oregon Health & Science University | College/University | Doctorate Degree | |
EXSCIENTIA PLC | Biotechnology | Chief Executive Officer | |
University of Cambridge | College/University | Undergraduate Degree | |
MedCity Ltd. | Chairman | ||
F-Star Beta Ltd.
F-Star Beta Ltd. BiotechnologyHealth Technology F-Star Beta Ltd. is a biopharmaceutical company that focused in the development of oncology and immune-oncology products. The company was founded on October 14, 2014 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Stanford University | College/University | Doctorate Degree | |
Dartmouth College | College/University | Undergraduate Degree | |
MEI PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
TRILLIUM THERAPEUTICS | Biotechnology | Director/Board Member | |
Two Paddles Consulting LLC | President | ||
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Doctorate Degree | |
Henley Management College | College/University | Masters Business Admin | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
F-star Alpha Ltd.
F-star Alpha Ltd. BiotechnologyHealth Technology F-star Alpha Ltd. develops novel bispecific antibody products. It focuses on treatment of breast and gastric cancer among a population of HER2-positive patients who do not respond or become resistant to current therapies. The company was founded in October 2013 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Atlantic Healthcare Plc
Atlantic Healthcare Plc Pharmaceuticals: MajorHealth Technology Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Pfizer Holdings International Luxembourg (PHIL) SARL
Pfizer Holdings International Luxembourg (PHIL) SARL Financial ConglomeratesFinance Part of Pfizer Inc., Pfizer Holdings International Luxembourg (PHIL) SARL is an investment holding company. The company is based in Luxembourg, Luxembourg. | Financial Conglomerates | Corporate Officer/Principal | |
IMMUNOCORE HOLDINGS PLC | Biotechnology | Chief Executive Officer | |
AVACTA GROUP PLC | Miscellaneous Commercial Services | Chairman |
Statistiche
Distribuzione geografica
Regno Unito | 23 |
Stati Uniti | 17 |
Australia | 3 |
Lussemburgo | 3 |
Svizzera | 3 |
Settori
Health Technology | 30 |
Consumer Services | 11 |
Commercial Services | 5 |
Finance | 2 |
Posizioni
Director/Board Member | 26 |
Corporate Officer/Principal | 13 |
Chief Executive Officer | 13 |
Chief Tech/Sci/R&D Officer | 8 |
Chairman | 6 |
Contatti più connessi
Insiders | |
---|---|
Eliot Forster | 35 |
Thomas Reynolds | 10 |
Jonathan Terrett | 9 |
Eugen Leo | 6 |
David Hallett | 4 |
Keith E. Wilson | 2 |
- Borsa valori
- Insiders
- Kristina Meyer
- Connessioni Società